Magnetic resonance spectroscopy evidence for declining gliosis in MS patients treated with ocrelizumab versus interferon beta-1a

BACKGROUND: Magnetic resonance spectroscopy quantitatively monitors biomarkers of neuron-myelin coupling (N-acetylaspartate (NAA)), and inflammation (total creatine (tCr), total choline (tCho), myo-inositol (mI)) in the brain. OBJECTIVE: This study aims to investigate how ocrelizumab and interferon...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Mult Scler J Exp Transl Clin
Päätekijät: MacMillan, Erin L, Schubert, Julia J, Vavasour, Irene M, Tam, Roger, Rauscher, Alexander, Taylor, Carolyn, White, Rick, Garren, Hideki, Clayton, David, Levesque, Victoria, Li, David KB, Kolind, Shannon H, Traboulsee, Anthony L
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: SAGE Publications 2019
Aiheet:
Original Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6796216/
https://ncbi.nlm.nih.gov/pubmed/31662881
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2055217319879952
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia